Naloxegol

Chemical formula: C₃₄H₅₃NO₁₁  Molecular mass: 651.794 g/mol  PubChem compound: 56959087

Therapeutic indications

Naloxegol is indicated for:

Opioid-induced constipation (OIC)

Population group: only adults (18 years old or older)

Naloxegol is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Naloxegol is contraindicated in the following cases:

Gastrointestinal obstruction or perforation

at least one of
Gastrointestinal obstruction
Gastrointestinal perforation

Strong CYP3A4 inhibitors

Strong CYP3A4 inhibitors

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: MOVANTIK Film-coated tablet
Summary of Product Characteristics (SPC) 2019: MOVENTIG Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈